Heart Rhythm
Volume 1, Issue 3 , Pages 276-283, September 2004

Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome

  • Wataru Shimizu, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
    • Laboratory of Molecular Genetics, National Cardiovascular Center, Suita, Japan
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Wataru Shimizu, Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565 Japan
  • ,
  • Takashi Noda, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
  • ,
  • Hiroshi Takaki, MD

      Affiliations

    • Department of Cardiovascular Dynamics, National Cardiovascular Center, Suita, Japan
  • ,
  • Noritoshi Nagaya, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
  • ,
  • Kazuhiro Satomi, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
  • ,
  • Takashi Kurita, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
  • ,
  • Kazuhiro Suyama, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
  • ,
  • Naohiko Aihara, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
  • ,
  • Kenji Sunagawa, MD, PhD

      Affiliations

    • Department of Cardiovascular Dynamics, National Cardiovascular Center, Suita, Japan
  • ,
  • Shigeyuki Echigo, MD

      Affiliations

    • Department of Pediatrics, National Cardiovascular Center, Suita, Japan
  • ,
  • Yoshihiro Miyamoto, MD, PhD

      Affiliations

    • Laboratory of Molecular Genetics, National Cardiovascular Center, Suita, Japan
  • ,
  • Yasunao Yoshimasa, MD, PhD

      Affiliations

    • Laboratory of Molecular Genetics, National Cardiovascular Center, Suita, Japan
  • ,
  • Kazufumi Nakamura, MD, PhD

      Affiliations

    • Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
  • ,
  • Tohru Ohe, MD, PhD

      Affiliations

    • Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
  • ,
  • Jeffrey A. Towbin, MD

      Affiliations

    • Department of Pediatrics (Cardiology), Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA
  • ,
  • Silvia G. Priori, MD, PhD

      Affiliations

    • Molecular Cardiology, Salvatore Maugeri Foundation, IRCCS, Pavia, Italy
  • ,
  • Shiro Kamakura, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan

Received 30 January 2004; accepted 14 April 2004.

Objectives

The aim of this study was to test the hypothesis that epinephrine test may have diagnostic value for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome (LQTS).

Background

A differential response of dynamic QT interval to epinephrine infusion between LQT1, LQT2, and LQT3 syndromes has been reported, indicating the potential diagnostic value of the epinephrine test for genotyping the three forms.

Methods

The responses of 12-lead ECG parameters to epinephrine were retrospectively examined in 15 LQT1, 10 LQT2, 8 LQT3, and 10 healthy volunteers to select the best ECG criteria for separating the four groups. The epinephrine test then was prospectively conducted in 42 probands clinically affected with LQTS, their 67 family members, and 10 new volunteers. The best criteria were applied in a blinded fashion to prospectively separate a different group of 31 LQT1, 23 LQT2, 6 LQT3, and 30 Control patients (10 genotype-negative LQT1, 10 genotype-negative LQT2 family members, and 10 volunteers).

Results

The sensitivity (penetrance) by ECG diagnostic criteria was lower in LQT1 (68%) than in LQT2 (83%) or LQT3 (83%) before epinephrine and was improved with steady-state epinephrine in LQT1 (87%) and LQT2 (91%) but not in LQT3 (83%), without the expense of specificity (100%). The sensitivity and specificity to differentiate LQT1 from LQT2 were 97% and 96%, those from LQT3 were 97% and 100%, and those from Control were 97% and 100%, respectively, when Δ mean corrected Q-Tend ≥35ms at steady state was used. The sensitivity and specificity to differentiate LQT2 from LQT3 or Control were 100% and 100%, respectively, when Δ mean corrected Q-Tend ≥80ms at peak was used.

Conclusions

Epinephrine infusion is a powerful test to predict the genotype of LQT1, LQT2, and LQT3 syndromes as well as to improve the clinical diagnosis of genotype-positive patients, especially those with LQT1 syndrome.

Key words:  Arrhythmia , Diagnosis , Long QT syndrome , Catecholamines , Genes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Shimizu was supported in part by the Japanese Cardiovascular Research Foundation, Vehicle Racing Commemorative Foundation, and Health Sciences Research Grants from the Ministry of Health, Labour and Welfare, and Research Grant for Cardiovascular Diseases (15C-6) from the Ministry of Health, Labour and Welfare, Japan. Dr. Priori was supported by an educational grant from the Leducq Foundation. Dr. Towbin was supported by grants from the National Institutes of Health (NIH), National Heart, Lung & Blood Institute (NHLBI) (R01 HL33843 and R01 HL51618).

PII: S1547-5271(04)00274-7

doi:10.1016/j.hrthm.2004.04.021

Heart Rhythm
Volume 1, Issue 3 , Pages 276-283, September 2004